Publisher
Springer International Publishing
Reference31 articles.
1. Van der Kwast T, Bubendorf L, Mazerolles C, Raspollini MR, Van Leenders GJ, Pihl CG, et al. Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Virchows Arch. 2013;463(3):367–77.
2. Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland. Version: Prostate 4.0.3.0
http://www.cap.org/web/oracle/webcenter/portalapp/pagehierarchy/cancer_protocol_templates.jspx?_adf.ctrl-state=3zi3gln3s_4&_afrLoop=386262653877404
#!. Accessed 15 Sept 2018.
3. Viglione MP, Potter S, Partin AW, Lesniak MS, Epstein JI. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy? Hum Pathol. 2002;33:796–800.
4. Rubin MA, Bismar TA, Curtis S, Montie JE. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol. 2004;28:946–52.
5. Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol. 2009;182:485–90.. discussion 490